Zephyrnet Logo

Tag: Commercializes

French Sales Subsidiary Eisai S.A.S. to Divest Rights for Loxapac And Parkinane LP to CNX Therapeutics

Eisai Co., Ltd. announced today that its French sales subsidiary Eisai S.A.S. entered into an agreement to transfer the rights in France, the French...

Top News

Unlocking the Power of AI: Reshaping Financial Services

AI is a hot topic and numerous articles are published stating that financial service companies not adopting AI today risk becoming obsolete tomorrow. However, as with...

Big pharma monopolies: major antitrust cases over the past decade

Antitrust laws are put in place to prevent unlawful activities like price fixing, as well as monopolies from forming, typically tied to big pharma....

Shoulder Innovations Announces Placement of New CFO and New VP Commercial Development | BioSpace

GRAND RAPIDS, Mich., Oct. 2, 2023 /PRNewswire/ -- Shoulder Innovations Inc. (SI), a Grand Rapids, Michigan based leader in the shoulder replacement implant market...

A $542M Raise Revolutionizes Lithium EV Battery Production

As the world rapidly transitions to clean energy, solutions for clean technologies such as lithium batteries for electric vehicles are ramping up. Fueling this...

FDA Approves Veopoz (pozelimab-bbfg) as the First Treatment for Children and Adults with CHAPLE Disease

FDA Approves Veopoz (pozelimab-bbfg) as the First Treatment for Children and Adults with CHAPLE DiseaseTARRYTOWN, N.Y., Aug. 18, 2023 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals,...

MCRA Aids Surmodics in Obtaining FDA Pre-Market Approval for Cardiovascular Drug-Coated Balloon | BioSpace

  WASHINGTON, Aug. 7, 2023 /PRNewswire/ -- MCRA, LLC, a leading medical device focused regulatory advisory firm and clinical research organization (CRO) integrating...

Capture6 Secures Over $8M Grant for Innovative Carbon Capture Technology

In a significant boost to the carbon capture industry, Capture6, a California-based startup, has secured a grant exceeding $8 million from the California Energy...

FDA Approves Roctavian (valoctocogene roxaparvovec-rvox) Gene Therapy for Adults with Severe Hemophilia A

FDA Approves Roctavian (valoctocogene roxaparvovec-rvox) Gene Therapy for Adults with Severe Hemophilia ASAN RAFAEL, Calif., June 29, 2023 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (Nasdaq:...

CGD’s CTO Florin Udrea inducted into IEEE ISPSD Hall of Fame

News: Microelectronics 20 June 2023 Cambridge GaN Devices Ltd (CGD) — which was spun out of the University of Cambridge Department of Engineering’s Electrical...

The Weekly Notable Startup Funding Report: 5/29/23

The Weekly Notable Startup Funding Report takes us on a trip across various ecosystems in the US, highlighting some of the notable funding activity...

Qunnect Debuts QU-APC Instrument with Interactive Demo at the 2023 Optical Fiber Communication Conference and Exhibition (OFC)

Qunnect, an industry leader in quantum-secure networking technology designed for scalable deployment on existing telecom fiber infrastructure, debuted their QU-APC instrument...

Shoulder Innovations Announces Oversubscribed $42 million Series D Financing

GRAND RAPIDS, Mich., March 6, 2023 /PRNewswire/ -- Shoulder Innovations Inc. (SI), a Grand Rapids, Michigan based leader in the shoulder replacement implant market,...

Latest Intelligence

spot_img
spot_img